X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (437) 437
Publication (42) 42
Conference Proceeding (34) 34
Newspaper Article (7) 7
Magazine Article (3) 3
Paper (3) 3
Book Chapter (2) 2
Book Review (2) 2
Dissertation (2) 2
Patent (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (133) 133
female (91) 91
index medicus (87) 87
middle aged (87) 87
male (85) 85
adult (84) 84
oncology (73) 73
aged (63) 63
hematology (51) 51
antineoplastic combined chemotherapy protocols - therapeutic use (39) 39
cancer (33) 33
treatment outcome (33) 33
chemotherapy (32) 32
aged, 80 and over (31) 31
lymphomas (31) 31
lymphoma (30) 30
prognosis (30) 30
adolescent (29) 29
non-hodgkins-lymphoma (25) 25
transplantation (25) 25
neoplasm staging (24) 24
therapy (24) 24
analysis (23) 23
optics (23) 23
disease-free survival (22) 22
rituximab (21) 21
care and treatment (20) 20
risk factors (18) 18
light emitting diodes (16) 16
medicine & public health (16) 16
abridged index medicus (15) 15
antineoplastic combined chemotherapy protocols - administration & dosage (15) 15
clinical trials (15) 15
combined modality therapy (15) 15
internal medicine (15) 15
spectroscopy (15) 15
young adult (15) 15
chronic lymphocytic-leukemia (14) 14
cyclophosphamide - administration & dosage (14) 14
diagnosis (14) 14
physics (14) 14
vincristine - administration & dosage (14) 14
antineoplastic agents - therapeutic use (13) 13
article (13) 13
cyclophosphamide (13) 13
disease (13) 13
doxorubicin - administration & dosage (13) 13
immunochemotherapy (13) 13
physics, atomic, molecular & chemical (13) 13
relapse (13) 13
research (13) 13
trial (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
b-cell lymphoma (12) 12
follicular lymphoma (12) 12
follow-up studies (12) 12
hematology, oncology and palliative medicine (12) 12
hemic and lymphatic diseases (12) 12
immunology (12) 12
survival (12) 12
tumors (12) 12
flow cytometry (11) 11
hodgkin lymphoma (11) 11
mantle cell lymphoma (11) 11
pathology (11) 11
prednisone - administration & dosage (11) 11
recurrence (11) 11
survival analysis (11) 11
survival rate (11) 11
time factors (11) 11
animals (10) 10
chemistry, physical (10) 10
cyclophosphamide - therapeutic use (10) 10
expression (10) 10
high-dose chemotherapy (10) 10
hodgkin disease - drug therapy (10) 10
hodgkin's disease (10) 10
medical colleges (10) 10
modulation (10) 10
physics, applied (10) 10
retrospective studies (10) 10
stem cells (10) 10
antibodies, monoclonal, murine-derived - administration & dosage (9) 9
antineoplastic agents - administration & dosage (9) 9
health aspects (9) 9
kaplan-meier estimate (9) 9
lymphoma, follicular - drug therapy (9) 9
medicine, general & internal (9) 9
patients (9) 9
prospective studies (9) 9
radiotherapy (9) 9
remission induction (9) 9
antibodies, monoclonal, murine-derived - therapeutic use (8) 8
combination (8) 8
dose-response relationship, drug (8) 8
doxorubicin (8) 8
drug administration schedule (8) 8
elderly-patients (8) 8
hodgkin disease - pathology (8) 8
infectious diseases (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Horwitz, Steven and O'Connor, Owen A and O'Connor, Owen and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fay, Keith and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Huttmann, Andreas and Illes, Arpad and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and Kato, Koji and Kirgner, Ilya and Kuo, Ching-Yuan and Lazaroiu, Mihaela Cornelia and Du, Katell Le and ... and ECHELON 2 Study Grp and ECHELON-2 Study Group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | COMBINATION | FLUDARABINE | STUDY-GROUP GLSG | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 4, pp. 331 - 344
BACKGROUND Brentuximab vedotin is an anti-CD30 antibody-drug conjugate that has been approved for relapsed and refractory Hodgkin's lymphoma. METHODS We... 
TRIAL | ABVD | MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | RESPONSE CRITERIA | DISEASE | PROGNOSTIC SCORE | OPEN-LABEL | TOXICITY | INTERGROUP | COOPERATIVE-ONCOLOGY-GROUP | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Immunoconjugates - administration & dosage | Young Adult | Aged, 80 and over | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Dacarbazine - administration & dosage | Immunologic Factors - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Immunologic Factors - adverse effects | Neoplasm Staging | Vinblastine | Hematology | Toxicity | Prophylaxis | Clinical trials | Oncology | Peripheral neuropathy | Cancer therapies | Doxorubicin | Survival | Lymphoma | Medicine | Dacarbazine | Chemotherapy | Bleomycin | CD30 antigen | Granulocyte colony-stimulating factor | Death | Colony-stimulating factor | Lymphomas | Leukocytes (granulocytic) | Drug dosages | Hodgkin's disease | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 19, pp. 1916 - 1927
Journal Article
G3-GENES GENOMES GENETICS, ISSN 2160-1836, 07/2019, Volume 9, Issue 7, pp. 2097 - 2106
Journal Article
by Aduszkiewicz, A and Ali, Y and Andronov, E and Antićić, T and Antoniou, N and Baatar, B and Bay, F and Blondel, A and Bogomilov, M and Brandin, A and Bravar, A and Brzychczyk, J and Bunyatov, S A and Busygina, O and Christakoglou, P and Ćirković, M and Czopowicz, T and Damyanova, A and Davis, N and Dembinski, H and Deveaux, M and Diakonos, F and Luise, S Di and Dominik, W and Dumarchez, J and Engel, R and Ereditato, A and Feofilov, G A and Fodor, Z and Garibov, A and Gaździcki, M and Golubeva, M and Grebieszkow, K and Grzeszczuk, A and Guber, F and Haesler, A and Hasegawa, T and Hervé, A E and Hierholzer, M and Hylen, J and Igolkin, S and Ivashkin, A and Johnson, S R and Kadija, K and Kapoyannis, A and Kaptur, E and Kiełbowicz, M and Kisiel, J and Knezević, N and Kobayashi, T and Kolesnikov, V I and Kolev, D and Kondratiev, V P and Korzenev, A and Kovalenko, V and Kowalik, K and Kowalski, S and Koziel, M and Krasnoperov, A and Kuich, M and Kurepin, A and Larsen, D and László, A and Lewicki, M and Lundberg, B and Lyubushkin, V V and Maćkowiak-Pawłowska, M and Maksiak, B and Malakhov, A I and Manić, D and Marchionni, A and Marcinek, A and Marino, A D and Marton, K and Mathes, H.-J and Matulewicz, T and Matveev, V and Melkumov, G L and Merzlaya, A and Messerly, B and Mills, G B and Morozov, S and Mrówczyński, S and Nagai, Y and Nakadaira, T and Naskręt, M and Nirkko, M and Nishikawa, K and Ozvenchuk, V and Panagiotou, A D and Paolone, V and Pavin, M and Petukhov, O and Pistillo, C and Płaneta, R and Popov, B A and Posiadała, M and Puławski, S and Puzović, J and Rameika, R and ... and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
The European Physical Journal C, ISSN 1434-6044, 2/2017, Volume 77, Issue 2, pp. 1 - 15
Journal Article
Journal Article
IEEE Photonics Technology Letters, ISSN 1041-1135, 10/2009, Volume 21, Issue 20, pp. 1511 - 1513
Journal Article
Journal of Lightwave Technology, ISSN 0733-8724, 12/2010, Volume 28, Issue 24, pp. 3512 - 3518
Journal Article
IEEE Journal of Selected Topics in Quantum Electronics, ISSN 1077-260X, 09/2010, Volume 16, Issue 5, pp. 1280 - 1289
Journal Article